PDCD1 and neoplasm: In murine models, compared with traditional radiotherapy, anti-PD-1 therapy relieves the inhibitory effect on immune cells such as TRM cells, while anti-MerTK can transform apoptosis caused by radiation into cell necrosis and turn macrophages near tumors from M2 to M1 and reduce tumor load (94).